|Articles|April 1, 2019
- Pharmaceutical Executive-04-01-2019
- Volume 39
- Issue 4
Pharmaceutical Executive, April 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Biosimilars Name Game Remains Thorny Issueabout 7 years ago
HBA's Woman of the Year 2019about 7 years ago
Sharing Your Voiceabout 7 years ago
Health Technology’s Double-Edged Swordabout 7 years ago
True Grit: Talent Management from the Ground Upabout 7 years ago
Reinventing Pharma’s Talent Searchabout 7 years ago
Hiring a Chief Diversity Officerabout 7 years ago
Are Pharma Marketers Fighting the Last War?about 7 years ago
Ready Patient Oneabout 7 years ago
Country Report: ChinaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5